Results 1-20 of 215 for drugs speaker:David Cullinane

Written Answers — Department of Health: Medicinal Products (23 Apr 2024)

David Cullinane: ...reimbursement support for Ozempic® (Semaglutide) is only available to those with eligibility under the general medical services scheme or the long-term illness scheme, and is not available on the drugs payment scheme; and if he will make a statement on the matter. [17966/24]

Select Committee on Health: Health (Miscellaneous Provisions) Bill 2024: Committee Stage (21 Mar 2024)

David Cullinane: ...a wider lens. The industry will look at it through its own lens but we have to look at it through a wider lens. I would imagine the logic of the directive is to have greater access to generic drugs, which we also need, but there is a need for caution on the part of the State. The pharmaceutical sector, as we know, is very important to the Irish economy. It creates a lot of jobs and a...

Select Committee on Health: Health (Miscellaneous Provisions) Bill 2024: Committee Stage (21 Mar 2024)

David Cullinane: ...states the US will be watching this with regard to anything that makes it more difficult for a company to protect its intellectual property, particularly when there is large investment in high-tech drugs, and we all know how important that is for patients and the industry. I get that there is a balance to be struck. I get all of these points. I fully understand the issues relating to...

Health Service Funding: Motion [Private Members] (24 Oct 2023)

David Cullinane: ..., demand increases, and pay increases; and — provide for new developments funding to advance vital projects across hospital bed capacity, community care reform, and taking further steps towards universal healthcare and reducing the cost of healthcare such as raising the medical card threshold and reducing the Drugs Payment Scheme threshold; — urgently bring forward a...

Investment in Healthcare: Statements (19 Oct 2023)

David Cullinane: ...we made the decision this Government made to deliberately underfund the health service, with all the consequences - a recruitment embargo in place, beds which are needed and may now not be funded, no new medicines for new drugs - the current Minister would be making exactly the same speech I am making today because he knows that what I am saying is true. It was really regrettable that...

Financial Resolutions 2023 - Financial Resolution No. 4: General (Resumed) (11 Oct 2023)

David Cullinane: ...no access to some of those. While they will still have access to the existing budget, because there is no new money or additional funding means that there will potentially be some high-tech innovative drugs and patients may now not be able to access them. One has to continue to increase funding in this area while achieving efficiencies in the overall spend, which I accept. There has...

Written Answers — Department of Health: Local Drugs Task Forces (13 Jul 2023)

David Cullinane: 766. To ask the Minister for Health the cost of returning funding to drug and alcohol taskforces to 2010 levels. [35161/23]

Written Answers — Department of Health: Departmental Schemes (13 Jul 2023)

David Cullinane: 759. To ask the Minister for Health the cost of reducing the drugs payment scheme threshold in increments of €10 to €0, additive, in tabular form. [35153/23]

Written Answers — Department of Health: Medicinal Products (21 Jun 2023)

David Cullinane: 199. To ask the Minister for Health if he has explored the possibility of recognising a product (details supplied) as medical treatment under the drugs payment scheme, instead of a food supplement; and if he will make a statement on the matter. [29969/23]

Written Answers — Department of Health: Medicinal Products (16 May 2023)

David Cullinane: ...ask the Minister for Health further to Parliamentary Question No. 785 of 13 January 2021, the status of the licensing and reimbursement of jorveza, used to treat eosinophilic oesophagitis, on the drug payment scheme. [23105/23]

Joint Oireachtas Committee on Health: The Role of Pharmacy Care in the Healthcare System: Irish Pharmacy Union (8 Mar 2023)

David Cullinane: Would those protocols have, for example, guidelines that would have a second and a third line of a drug? The process would be highly regulated. Step-by-step guidelines would be available. Lots of protections would be in place as part of the process. That is the whole logic of having a protocol.

Joint Oireachtas Committee on Health: The Role of Pharmacy Care in the Healthcare System: Irish Pharmacy Union (8 Mar 2023)

David Cullinane: If that officer position was in place, would that officer have a role in the State's policy on drug reimbursement or drug supply? That is a very cumbersome process, which this committee wants to look at as well. Would Ms Foley envisage the officer having a role in that space?

Written Answers — Department of Justice and Equality: Antisocial Behaviour (8 Nov 2022)

David Cullinane: 840. To ask the Tánaiste and Minister for Justice and Equality if her attention has been drawn to the number of incidents of drug use, crime and antisocial behaviour around Railway Square in County Waterford. [54273/22]

Written Answers — Department of Health: Medicinal Products (18 Oct 2022)

David Cullinane: 676. To ask the Minister for Health if NDT thyroid tablets have been removed from the reimbursement list for the drugs payment scheme and medical card; is so, the reason for same; if they will be replaced on this list; and if he will make a statement on the matter. [51107/22]

Joint Oireachtas Committee on Health: Long Covid and Monkeypox: Discussion (12 Oct 2022)

David Cullinane: ...entered when we went into lockdown in March 2020. That is still her life at this time. Many of those who contracted Covid also have long Covid. I know there are issues around the Evusheld antibody drug. What additional supports or plans are in place for patients who are immunocompromised? What access is available to those antiviral and antibody medications such as Evusheld? As...

Written Answers — Department of Health: Medicinal Products (27 Sep 2022)

David Cullinane: 511. To ask the Minister for Health if he will address the matter raised in correspondence (details supplied) in relation to the drugs payment scheme card; and if he will make a statement on the matter. [46982/22]

Written Answers — Department of Health: Medicinal Products (14 Sep 2022)

David Cullinane: 519. To ask the Minister for Health if he will reconsider the inclusion of the drug Praluent for reimbursement in the drug payment scheme; if he will provide an update on same; and if he will make a statement on the matter. [44507/22]

Written Answers — Department of Health: Health Service Executive (5 Jul 2022)

David Cullinane: 617. To ask the Minister for Health the role and composition of the HSE drugs group; and if he will make a statement on the matter. [35338/22]

Health (Miscellaneous Provisions) (No. 2) Bill 2022: Second Stage (1 Jul 2022)

David Cullinane: ...hospital charges. The measure in the Bill relates to children only and should be abolished for all patients. We have the issue of car parking and prescription charges. The threshold for the drug payment scheme is still too high, although it was reduced in the previous budget. An awful lot more needs to be done to reduce the cost of healthcare. For me, however, the biggest issue is...

Written Answers — Department of Health: Pharmacy Services (23 Jun 2022)

David Cullinane: 415. To ask the Minister for Health if he has plans to allow pharmacists to be able to supply additional drugs and medications without a prescription and without having to resort to a general practitioner; if so, the name of the drug and the medication; and if he will make a statement on the matter. [33346/22]